Committee
Consult the user guide
For assistance, please contact us
Consult the user guide
For assistance, please contact us
Add search criteria
Results: 1 - 60 of 147
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-09-22 12:27
Thank you to all of the witnesses for the varied and interesting testimony.
I think I'm going to start with you, Dr. Tomkins. Coming from Yukon territory, I'm certainly concerned about dental care, as you are, in rural and underserved areas.
One area I'm quite interested in is the role of dental therapists. I know that you've addressed getting dentists more connected to remote areas and some of the barriers there—surgical centres—but what about dental therapists? We know that Saskatchewan has been a leader in that area. I'm just wondering what your thoughts are on this particular cadre and how we might scale them up as practitioners as well.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-09-22 12:29
If you wouldn't mind, answer very quickly, please, because I have a few more questions.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-09-22 12:29
Thank you very much.
Ms. Wilson, I think you mentioned in your remarks the idea of training early child educators to detect and be familiar with speech-language pathology. I'm wondering if you could briefly elaborate on that particular area. Given the real shortage of practitioners, I think we need to expand the knowledge and the ability to screen and detect.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-09-22 12:31
Thank you. If time permits, I may come back to you.
I want to ask Ms. Masotti or Ms. Sonea this: The vaping stats you related are certainly alarming, in terms of the increasing trends, although I think the data you quoted stopped in 2019. I wonder if you have information on more recent effects—particularly pandemic-related effects—and also evidence about vaping and tobacco use, not just nicotine addiction, and therefore the link to cancer and what legislative aspects may be needed—all in the remaining 30 seconds I have.
Thanks.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-21 12:35
Thank you very much, Mr. Chair.
Thank you to all the witnesses for appearing. You have all from various angles, I think, today described how science is a method and not a person or a degree, and not a decision. Fundamentally, it's about careful and documented observation that is reproducible and transparent.
I liked the way that Mr. Bonnell described the importance of validation of surveys by fisher industry knowledge, because I think that helps to ground-truth the scientific method behind stock assessment.
My first question for Mr. Bonnell is actually not quite about that. It's about indigenous knowledge. We know that indigenous peoples have thousands of years of experience in fishing sustainably. Their insight is central to understanding how we nurture fisheries and helps to inform decisions regarding commercial fishing and prioritizing sustainability.
I'm wondering, with regard to Ocean Choice, whether you have a framework in place for indigenous consultation. Even if not, how can DFO support ensuring indigenous knowledge is included in commercial fishing?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-21 12:38
Thank you. That's very apropos for today's National Indigenous Peoples Day.
I want to turn to Mr. Prevost. I'm very grateful that you're here. This is the first time I think in this series that we're hearing about fish being used as bait and how important that is to the overall sustainability of the crustacean industry. I'm hoping to see this reflected in our report.
I was also interested when you talked about the crustacean fishery as being very traditional. Of course tradition is so important to community investment in the fishery, continuation of the livelihood, etc., but on the other hand, there may be practices that are slower to adapt to modern reality.
I'm just wondering if you could comment on DFO's role, or potential role, in fostering culture change in adapting to the modern realities of stocks.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-21 12:40
Thank you.
I believe I have 15 seconds left. I have a short question for Dr. Vascotto.
You gave a really good overview of the Facebook cable situation with Mr. Perkins' questions. Going back to that, was there a specific shortcoming of DFO that you could outline in about 10 seconds?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-20 17:17
Thank you, Mr. Chair.
Thanks to all of the representatives from the agency for attending today.
I'd like to start with Dr. Poliquin. It's good to see you again. I know you've spoken previously to this committee on updates. One of the subject areas is around genomics.
Could you update the committee on how genomics has helped us respond to the pandemic in its more recent phases, and maybe you could comment on the modelling exercises you are currently undertaking?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-20 17:20
Thank you.
I wonder whether, on that note, you can give us any inkling of what you are anticipating. We're always looking towards the next season, whether that's the summer season of travel and gatherings or the fall return to school or the winter of being back inside. There's always another season coming. What are you seeing in terms of patterns for late summer into fall at this point?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-20 17:22
Thanks.
Mr. Chair, do I still have time for one more question?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-20 17:22
I wonder.... I forget what my question was. There are so many questions.
It's for whoever can jump in, but maybe this would be back to Ms. Evans. Just on that note, I wonder about your strategies for getting Canadians to get their doses—we know that we have a lag in third dose uptake—in anticipation of what might be coming at us in the fall.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-15 17:43
Thank you, Mr. Chair.
Thank you, Minister Bennett and all the officials, for appearing today. Thanks for the hard work that all of you are doing.
Mr. Chair, I would like to save the last two minutes of my six minutes for Mr. Morrice to have a chance for a question, if you'd be kind enough to help me with that.
Minister Bennett, I'm certainly very happy to see the B.C. exemption. I know you agree with me that the toxic drug crisis is not a “B.C.-only” problem. My constituency of the Yukon still has among the most per capita deaths in the toxic drug crisis. It's a crisis that touches communities across the country—families, parents, children, indigenous and racialized people, and young people everywhere. I believe the agreement is a big step in the right direction.
I'd love to hear your thoughts on the potential for decriminalization of personal possession in other jurisdictions in Canada and your thoughts on a future national approach.
Particularly, have other jurisdictions already expressed an interest in pursuing decriminalization of personal possession in their regions? Can you update us on which ones?
Maybe I'll stop there and let you speak to that.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-15 17:46
Thank you.
Can you elaborate a bit on when you have or are expecting applications from municipalities and how that will actually work in practice—particularly as we gain experience from the B.C. example—when it's not the entire jurisdiction, the province or the territory, that is actually pursuing the request?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-15 17:47
Yes. Thank you very much.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-14 12:37
Thank you, Mr. Chair.
Thank you to all of the witnesses for appearing here today.
Certainly one of the interesting themes out of this is what does science mean? Are we all arriving at a common understanding of what science is—science as an exercise to integrate knowledge and evidence from all available sources without bias? It is on that theme that I have a few questions.
Mr. Trites, I was really interested in your recommendations around research clusters. I want to bring that out a bit more. I wonder if you could describe how a research cluster might work. Maybe you could use the example of how that might work with Pacific salmon in particular.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-14 12:39
Thank you.
Dr. Rangeley, at the end of your five minutes you mentioned a better bringing in of the indigenous perspective and indigenous knowledge. I wondered if you could elaborate a bit on how you see doing this.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-14 12:41
Thanks.
Mr. Sean Jones, I know you spoke earlier on the co-governance perspective, particularly with the regulatory hat. I wonder if you could maybe further elaborate on the implementation of co-governance and incorporating indigenous knowledge.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-14 12:42
Thank you very much.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-13 16:56
Thank you to all of the witnesses for your testimony, and particularly you, Ms. Goulding, for having your personal experience and your advocacy, despite your own challenges. It's fascinating and so important to hear your testimony, but I'm going to give you a break.
Dr. Arts, you talked about the advantage that we have, with so many people infected, as a kind of potential for cohorts. But I'm going to pivot to Dr. Falcone for now and ask if it is also a disadvantage that COVID is now becoming so common? I think I know more people who have had COVID than have not. Maybe I'm mixing in the wrong crowds. Personally, I've been spared so far, but is long COVID clinically distinct enough that we will still be able to recognize it given the increasing prevalence of people who have had COVID, or will we really be dependent on that search for biomarkers?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-13 16:59
Yes, and it was more in that latter category of people presenting with non-specific symptoms who may have had COVID, how to distinguish the long COVID from perhaps other syndromes for which we as clinicians have always had to tease out what's going on, especially when we're talking about therapeutics.
I want to use my remaining time to turn to Dr. Arts. It's really interesting to hear your observation about the postpandemic effects and how you see a peak of neurodegenerative diseases in the years following. Surely we must then be seeing that with seasonal influenza and looking for connections. I know that perhaps we are seeking to better define the connection. I'm wondering if you could comment on that relationship. What is the common path of physiology potentially between influenza and neurodegenerative diseases and COVID and neurodegenerative diseases? Is it the inflammatory response? Given that they're very different viruses, is there something else, or is that still what we're looking for?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-09 12:50
Thank you, Mr. Chair.
I appreciate all of the witnesses' testimony. It is indeed hard to know where to begin, but I'm going to start on the west coast. If time allows, I'll move to the other side.
Mr. Bos, like Mr. Morrissey, I'm thinking of what the themes are for thinking forward. I'm hearing about adaptation to current challenges, the need for more transparency, the need for more connection and partnership with both industry and recreational fishers, and the need to integrate social science.
I am also interested in these examples of where things have really worked well. Mr. Bos, you mentioned the Sooke chinook enhancement initiative. I wonder if you can talk more about how we can elevate and use that example.
What are the steps to see how we can use that excellent example of collaboration and success in other areas? Also, reflecting on Ms. Barron's comments on being involved in the Pacific salmon strategy, how can we be involved to make that ultimately a success?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-09 12:53
Thank you very much.
In view of time, I want to go to Monsieur Lanteigne.
You spoke very well at the outset about the multiple challenges that we face and that DFO faces.
I wonder whether you think that DFO as an organization has fundamentally changed over the years or whether it's just a matter of keeping up and adjusting a strategic approach to compete with today's multiple challenges?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-08 17:32
Good afternoon, everyone. I want to thank all of the officials for appearing today.
I would like to start with Dr. Strong, on the theme of long COVID, the state of research, and what you see as the trends, where we're going and the plans for long COVID.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-08 17:33
Thank you very much.
Dr. Lucas, on the clinical patient side in terms of support for long COVID, I think we're all worried about the burden that long COVID is proving to present, with rates of 20% to maybe 30% of COVID disease leading to long COVID syndromes. That is clearly concerning. I hear probably every week from my own constituents....
I wonder if you could give me a bit of the state of where we are with support and projected support for long COVID.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-08 17:35
Thank you very much.
I want to pivot a bit. I noticed in the supplementary estimates some additional funding for the vaccine injury support program.
Dr. Tam, I wonder if you would be able to provide us a bit of an update in terms of the initial few months of that injury support program's existence and how that may be or will be perhaps increasing the confidence that Canadians have in our vaccine system.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-08 17:37
Thank you.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 20:48
Thank you to the two panellists for the very interesting testimony.
I'm going to let you know that I'm new to this committee, but as a former practitioner and public health physician, I'm not completely new to the issue of MAID.
I want to ask you, Ms. Montes, a question on what you call the “prohibition” approach until a certain age, applied for certain conditions. Maybe you can comment. At what age do you consider the frontal lobes have achieved maturity and that executive functioning is, in fact, now at adult stage?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 20:49
Yes, maybe I'll rephrase it.
In some of our deliberations—for instance, on adolescence and drug or cannabis use—we often consider the maturity of the adolescent. In fact, science tells us that maturity of the frontal lobes is not achieved until age 25. At some point, we have to make decisions about relative maturity. There is, obviously, no black and white cut-off.
I'm wondering where you apply that cut-off in your own experience and practice.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 20:51
The point I'm trying to make is that these things are relational. To the point of the previous witnesses, decisional capacity is relative, and the severity of a situation has to be considered in the context of the condition and maturity of that individual.
Mr. Carnevale, I wonder if you can comment.
When you say we need the youth voice, what have we neglected and where can we do better in bringing the voice of young people into decision-making?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 16:43
Thank you to all the witnesses for appearing today. It's been very interesting testimony so far.
I'm going to go first to Mr. Aziz again, on the subject of the challenges with rising food costs, particularly in the north. I know we have a nutrition north program, but, given the challenges, especially through the pandemic and with rising costs, I wonder, Mr. Aziz, if you could comment on how we can ensure access to nutritious food choices, especially of fruits and vegetables, and a variety of food choices, and how we continue to ensure access, particularly in rural northern and remote communities.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 16:45
Thank you.
Ms. Clifford, you mentioned a number of research projects under way. I think you mentioned emergency research to understand some of the pandemic's impacts on children's health. Can you comment on the research turnaround and how we can look forward to policy changes based on research findings on an accelerated basis, just because of the urgency of some of what we think has happened or understand from other sources has happened through the pandemic?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 16:47
Thank you very much.
Perhaps I have time to squeeze in one more question, for Ms. Weber.
You mentioned the stabilization of vaping, which is great to see and which is what I'm seeing, at least anecdotally, in high schools around here.
Very quickly, can you comment on the link between vaping and tobacco use and what you have seen so far, and whether there is any ongoing trend of there being a gateway from vaping to tobacco among children and youth?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-06 16:48
Thank you very much.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-01 17:55
Thank you, Mr. Chair.
Thank you to all three witnesses.
I also want to give a shout-out to Ms. Paes for the work of pharmacists during the pandemic and the incredible frontline work. You were really part of the last people still operating and serving Canadians, so thank you for that.
I'm also going to concentrate my questions on you, Dr. MacDonald. It's really good to see you. You gave a real tour de force in five minutes. I can't believe how much you covered that is left to unpack.
One area in which we know we have lost ground is getting adults their third dose or, in some cases, their fourth dose. That is leaving us more vulnerable. We don't know what's coming by way of recommendations, but knowing what you do about hesitancy, what do you think we need to do to promote or convince a behaviour change to encourage Canadians to get their third dose and the doses that will be recommended in future?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-01 17:59
I'm not over yet.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-01 17:59
Okay, that's great.
I'm going to try to squeeze two more questions in.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-06-01 17:59
This is fantastic.
The first is for you, Noni. With your WHO hat on, regarding global vaccines, I just read a headline that the South African company has no market for vaccine production. There's no demand. We know that on vaccine hesitancy, where we're trying to get vaccine to some of the less well-resourced countries, it's probably an even greater challenge than it is here.
Are there any quick comments on that?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-12 12:29
Thank you very much.
I will also take advantage of the time remaining for Mr. Chamberlin—Galagame'.
I'm from the Yukon, and I'm actually on this committee because of salmon, or my concerns about salmon. My question may be a little bit vague, but it's really going back to your point about the fundamental role of first nations in reconciliation and in being at the table in decisions about salmon.
My question is about governance and the relationship between the governance of B.C. first nations and the role that you play or should play. Is it a matter of goodwill? Is it a matter of governments? Are there fundamental changes in our relationships with first nations and provincial and federal partners that need to take place?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-12 12:32
Thank you very much for that.
I'm trying to focus on solutions as we get towards the end of this study.
Ms. Sutcliffe, within DFO, are we talking about a process issue, a structural issue, a cultural issue? What would the next steps be to get CSAS and DFO to more of an integrated scientific approach? What would be your more immediate recommendations?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-12 12:34
It would be great to get written submissions.
I'm getting the eye, so I guess I'm done. Thank you so much.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-09 16:39
Thank you, Mr. Chair.
I would echo the thanks to all the witnesses for re-appearing and for bringing the road map that speaks to solutions. Like my colleagues, I'd like to recognize National Nursing Week and Indigenous Nurses Day.
Dr. Smart, the situation is so critical that we urgently need to find solutions and establish recommendations. In addition to the road map that the three organizations have brought to us, you released a statement just today, I believe, on the need for the federal government to lead, in collaboration with provinces and territories, a drive to increase Canada's supply and availability of family doctors. I think this is critical. What I really liked in that statement was that you talked about reimagining family medicine, which goes back to that concept of reforming primary care.
Maybe you could say a few words on this. What does the modern, happy, useful and efficient 21st century family physician look like? Let's project a few months or a couple of years into the future.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-09 16:43
Thank you.
Dr. Bouchard, let's flip that around a bit. In this primary care team, anchored by that happy family physician, tell me about the patient and the client in the middle. How are they going to benefit?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-09 16:44
Thank you.
Back to you, Dr. Smart.
Clearly, there are federal investments committed either in the budget or through the platform commitments; namely, mental health care, primary care, reform, and addressing the backlog. As you have all said, “It's more than just money.”
You spend a lot of time talking with colleagues and associations around the country. How do you see the federal role in igniting change? We're in a federated system. The provinces have control over health care delivery, yet we need a driver. We need to get there.
Dr. Smart, could you comment on how best the federal government can position itself, in 30 seconds or less.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-05 13:13
My thanks to Mr. Reynolds and the rest of the fascinating witnesses. To think that six months ago I wouldn't have been able to tell you what a pinniped was.
Mr. Chair, I will be sharing my time with Ms. May, so I'll have two and a half minutes.
I want to go back to Mr. Oldford.
Thanks for being here. I notice in your profile that your research interests include parameter estimation, uncertainty analysis and modelling ecological networks. It seems that one of the linchpins for how science in DFO gets translated into options and recommendations is through this scientific advice report. But where you have varying quality of science and uncertain data, I wonder if you can describe some of the challenges in collating uncertainties and inconsistencies into advice based on science, and how you would use the tools such as uncertainty analysis and parameter estimation to inform that advice.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-05 13:16
Yes. Thank you very much.
I'll now cede my time to Ms. May.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-03 16:57
Thank you very much.
Thanks to all three panellists for a really fascinating discourse. Certainly, a common theme is incorporating first nations indigenous leadership and patient experience into program design but also maintaining that public accountability of running what needs to be a publicly funded institution. I appreciate that there is a balance.
Dr. Adams, you and I have known each other in many different roles over the years. When I look back at your experience with the First Nations Health Authority, you were one of the instrumental people, I think, in helping to design the First Nations Health Authority. I think it's a really good example of incorporating first nations leadership into program design.
I wonder if you could comment briefly on what you learned from that and how you might apply that to how we can address some of the inefficiencies, perhaps, that have been witnessed in talking about NIHB.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-03 17:01
I'll let Ms. Atwin continue for the six minutes.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-02 17:33
Thank you, Mr. Chair.
Is Dr. Njoo still with us? Yes.
Dr. Njoo, just to perhaps mix it up a bit and change the theme, I'm just wondering what, to your mind, are some of the infectious disease priorities that may have suffered as a result of our necessary focus on the pandemic over the last two years. Also, how is the agency looking to address some of the backlog of work in some priority areas of infectious disease?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-05-02 17:37
Thank you very much.
I'm glad you mentioned antimicrobial resistance, because it's certainly something we cannot turn our attention away from.
This is a question for, perhaps, Ms. Evans.
I notice that in budget 2022 the agency has been designated over $400 million related to surveillance and risk assessment. Given that this is Emergency Preparedness Week, I wonder if you could talk about how this funding might help to strengthen surveillance with a view to managing and responding to and preparing for potential future phases of this pandemic but also, equally as important, potentially other infectious disease threats and pandemics, as quickly as you can.
Thank you.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-28 12:44
Thank you very much.
Thank you to the witnesses for the fascinating testimony.
As a public health physician, especially having been managing the public health response to the pandemic in the last couple of years, I certainly recognize many of the similar themes about the distinction between the science and making sure the science is there, and the many factors that influence a policy decision.
The first question I have is for Mr. Staley.
You talked with some diplomacy about the muted science that occurred during the Harper era. I think it's important to be very clear about how destructive that was not just for fisheries science but also in general for promoting and practising evidence-based policy in the federal government.
Specifically, you also mentioned the Pacific salmon strategy. This is important for me as a Yukon representative. I wonder if you could discuss the role of science in the Pacific salmon strategy and how you hope to see science and traditional knowledge advance the work that we need to do to implement the strategy.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-28 12:48
Mr. Staley, I'm going to have to cut you off because my time is so limited.
I want to go to Dr. Riddell.
You also mentioned the Pacific salmon strategy. What are the opportunities for really taking some of these lessons and applying scientific knowledge and traditional knowledge to the Pacific salmon initiative?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-28 12:49
Thank you.
In my remaining seconds, I'll get Dr. Whitney to comment briefly.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-26 13:04
Thank you.
Thank you, Dr. Nemer, for appearing today.
There was a time when this office didn't exist. It's relatively new, having been established or at least re-established in 2017 by the Liberal government.
In general, since taking office, where have you seen gaps in science informing policy? How has your office attempted to correct this? Maybe this is a chance for you to elaborate on some of your initial comments.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-26 13:07
Thank you very much. That's very helpful.
I know you've mentioned the pandemic a few times. We had many examples of trying to act on emerging science. One could not always wait for peer review, let alone duplicate studies.
Can you talk a little bit about how you see some learnings there from using emerging scientific findings that may not have had time for peer review but that may be important enough to change policy?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-26 13:09
To take a slightly different or more focused tack, I have heard and read reports on the lack or relative lack of climate change analysis into fish stock estimates by DFO. It sounds like there are some recent efforts and funding boosts in order to support better climate change analysis.
I wonder if you could comment on that particular area and the importance of modelling climate change effects into fish stock populations.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-26 13:10
Thank you very much.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-25 17:22
Thank you very much. I feel very much like Mr. Lake. This has been excellent testimony from all around the table. It's hard to know where to focus one's five minutes.
I do think I will start with Dr. Sahgal.
I find that even though you are in a hyperspecialized practice, you spoke very eloquently about rural needs. We have almost a dichotomy between the need for super specialization, particularly in our modern age, but also the need for that broad spectrum of practice.
Particularly with our rural and remote lens, how can we best optimize that mix between broad generalists in medical practice and finely honed specialists?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-25 17:25
Thank you.
Dr. Peachey, as you may or may not remember, I was in Yukon as a practitioner when you did some extensive data work there that I think shed a lot of light on what the needs were. I wonder if you could talk about some examples of where that deep data search has really clarified the needs around provider mix and how we can really elevate that conversation around the country.
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-25 17:27
Thank you.
Mr. Chair, do I have any room for Dr. Gratzer to perhaps provide a brief follow-up comment in that regard?
View Brendan Hanley Profile
Lib. (YT)
View Brendan Hanley Profile
2022-04-07 12:09
Thank you to the three of you for very interesting testimony.
I'm going to continue Mr. Small's prevention theme and dig a bit.
First, Madame Langlois, you gave very interesting testimony on the effects...and had a number of recommendations, but I wonder if you can comment further. Overall, we're seeing high safety records with container traffic—it's incredibly safe—and a low proportion of container spills. On the other hand, we see rising container traffic and a rising number of containers per ship.
I wonder, given your experience, if you can comment on the forgivability of container ship spills. Our oceans are becoming increasingly vulnerable. Our coastlines are becoming increasingly vulnerable. Is there or should there be a target for the number or proportion of forgivable spills? I think Mr. Zimmer mentioned there was a 0.001% crash rate, but if we compare that with the rate in civil aviation, I think that's still a few zeros behind our forgivability for civil aviation, commercial aviation at least, in terms of fatal crash rates.
I would be very interested in your perspective on that forgivable rate of container spills.
Results: 1 - 60 of 147 | Page: 1 of 3

1
2
3
>
>|
Export As: XML CSV RSS

For more data options, please see Open Data